Credit Suisse’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Credit Suisse’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-102,160	Closed	-$2.46M	–	4870
2014 Q2	$2.46M	Sell	102,160 -94,244	-48%	-$982K	﹤0.01%	2550
2014 Q1	$1.18M	Buy	196,404 +4,103	+2%	+$28.6K	﹤0.01%	2975
2013 Q4	$1.15M	Buy	192,301 +33,635	+21%	+$156K	﹤0.01%	3148
2013 Q3	$824K	Buy	158,666 +16,985	+12%	+$74.4K	﹤0.01%	3117
2013 Q2	$511K	Buy	+141,681	New	+$579K	﹤0.01%	3287

Credit Suisse's IDIX Position: Q3 2014 in Review

Credit Suisse sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 102,160 shares — an estimated $2.46M sold.

Credit Suisse first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $2.46M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Credit Suisse reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Credit Suisse sold 102,160 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $2.46M.
Credit Suisse first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Credit Suisse's IDENIX PHARMACEUTICALS INC position peaked at $2.46M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Credit Suisse's 13F filing for Q3 2014, filed 14 Nov 2014.